Mangoceuticals (MGRX) Shares Outstanding (2022 - 2026)

Mangoceuticals (MGRX) has 4 years of Shares Outstanding (Entity) data on file, last reported at $10.1 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding (Entity) rose 408.93% year-over-year to $10.1 million; the trailing twelve-month figure through Dec 2025 stood at $10.1 million (up 408.93% YoY), and the FY2025 full-year result was $10.1 million, up 408.93% from the prior year.
• Shares Outstanding (Entity) grew to $10.1 million in Q4 2025, from $7.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $10.1 million in Q4 2025 to a low of $719908.0 in Q4 2022.
• A 4-year average of $2.9 million and a median of $1.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) soared 49.22% in 2023 and jumped 408.93% in 2025, its largest moves.
• Tracing MGRX's Shares Outstanding (Entity) over 4 years: stood at $719908.0 in 2022, then surged by 49.22% to $1.1 million in 2023, then soared by 84.22% to $2.0 million in 2024, then jumped by 408.93% to $10.1 million in 2025.
• Business Quant data shows MGRX's Shares Outstanding (Entity) at $10.1 million in Q4 2025, $7.3 million in Q2 2025, and $4.6 million in Q1 2025.